GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (BOM:533543) » Definitions » Shiller PE Ratio

Brooks Laboratories (BOM:533543) Shiller PE Ratio : (As of May. 11, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Brooks Laboratories Shiller PE Ratio Historical Data

The historical data trend for Brooks Laboratories's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories Shiller PE Ratio Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 156.34 - - -

Brooks Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Brooks Laboratories's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brooks Laboratories's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's Shiller PE Ratio falls into.


;
;

Brooks Laboratories Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Brooks Laboratories's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Brooks Laboratories's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-1.75/158.3229*158.3229
=-1.750

Current CPI (Dec. 2024) = 158.3229.

Brooks Laboratories Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 1.197 97.163 1.950
201506 0.776 99.841 1.231
201509 0.867 101.753 1.349
201512 1.429 102.901 2.199
201603 2.362 102.518 3.648
201606 0.834 105.961 1.246
201609 0.372 105.961 0.556
201612 0.248 105.196 0.373
201703 -0.603 105.196 -0.908
201706 -2.997 107.109 -4.430
201709 -1.544 109.021 -2.242
201712 -1.338 109.404 -1.936
201803 -1.156 109.786 -1.667
201806 -1.891 111.317 -2.690
201809 -1.024 115.142 -1.408
201812 -1.098 115.142 -1.510
201903 -3.350 118.202 -4.487
201906 -2.288 120.880 -2.997
201909 -0.925 123.175 -1.189
201912 -1.379 126.235 -1.730
202003 -9.569 124.705 -12.149
202006 -1.159 127.000 -1.445
202009 1.337 130.118 1.627
202012 -1.040 130.889 -1.258
202103 -6.170 131.771 -7.413
202106 -0.465 134.084 -0.549
202109 -1.951 135.847 -2.274
202112 -2.654 138.161 -3.041
202203 -2.630 138.822 -2.999
202206 -2.766 142.347 -3.076
202209 -3.190 144.661 -3.491
202212 -2.030 145.763 -2.205
202303 -5.850 146.865 -6.306
202306 -1.810 150.280 -1.907
202309 -0.600 151.492 -0.627
202312 -1.510 152.924 -1.563
202403 -3.750 153.035 -3.880
202406 -0.940 155.789 -0.955
202409 -1.510 157.882 -1.514
202412 -1.750 158.323 -1.750

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Brooks Laboratories  (BOM:533543) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Brooks Laboratories Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. The company operates under one segment: Pharmaceutical products including ingredients and intermediaries. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories Headlines

No Headlines